These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 26614868)

  • 21. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; Rajkumar SV
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
    Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymptomatic monoclonal gammopathies.
    Bories C; Jagannath S
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S78-86. PubMed ID: 25486961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].
    Hübel K; Hallek M
    Internist (Berl); 2013 Jun; 54(6):709-14. PubMed ID: 23670732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.
    Paiva B; Vídriales MB; Rosiñol L; Martínez-López J; Mateos MV; Ocio EM; Montalbán MÁ; Cordón L; Gutiérrez NC; Corchete L; Oriol A; Terol MJ; Echeveste MA; De Paz R; De Arriba F; Palomera L; de la Rubia J; Díaz-Mediavilla J; Granell M; Gorosquieta A; Alegre A; Orfao A; Lahuerta JJ; Bladé J; San Miguel JF;
    Leukemia; 2013 Oct; 27(10):2056-61. PubMed ID: 23743858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal gammopathy and multiple myeloma in the elderly.
    Kyle RA
    Baillieres Clin Haematol; 1987 Jun; 1(2):533-57. PubMed ID: 3322448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MGUS and smoldering myeloma: the most prevalent of plasma cell dyscrasias.
    Richardson PG; Laubach J; Mitsiades CS; Schlossman RL; Ghobrial IM; Munshi NC; Anderson KC
    Oncology (Williston Park); 2011 Jun; 25(7):594, 596. PubMed ID: 21888257
    [No Abstract]   [Full Text] [Related]  

  • 28. A retrospective study to evaluate the work-up and follow-up of patients with monoclonal gammopathy of undetermined significance.
    Berenson JR; Yellin O; Quiery A; Brady J; Patel R; Wong SF; Colbourn D; Gravenor D; Tiffany N; Shamasunder HK; Waterman B; Melamed K; Wirtschafter E
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):336-41. PubMed ID: 21816371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).
    Bird J; Behrens J; Westin J; Turesson I; Drayson M; Beetham R; D'Sa S; Soutar R; Waage A; Gulbrandsen N; Gregersen H; Low E;
    Br J Haematol; 2009 Oct; 147(1):22-42. PubMed ID: 19673884
    [No Abstract]   [Full Text] [Related]  

  • 30. MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).
    Xiao R; Cerny J; Devitt K; Dresser K; Nath R; Ramanathan M; Rodig SJ; Chen BJ; Woda BA; Yu H
    Am J Surg Pathol; 2014 Jun; 38(6):776-83. PubMed ID: 24705315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distortions but not Definitive Peaks by Capillary Serum Protein Electrophoresis Indicate Monoclonal Gammopathy of Undetermined Significance rather than Multiple Myeloma.
    Liang CA; Zhang L; Segal G; Dasgupta A; Nguyen AND; Wahed A
    Ann Clin Lab Sci; 2020 Jan; 50(1):151-152. PubMed ID: 32161026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
    Iwanaga M; Tomonaga M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overweight/Obesity and Monoclonal Gammopathy of Undetermined Significance.
    Georgakopoulou R; Andrikopoulou A; Sergentanis TN; Fiste O; Zagouri F; Gavriatopoulou M; Psaltopoulou T; Kastritis E; Terpos E; Dimopoulos MA
    Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):361-367. PubMed ID: 33582053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomes.
    Garderet L; Al Hariri M; Wasielica-Poslednik J; Munder M; Kormányos K; Pena C; Gozzetti A; Zhou X; Waszczuk-Gajda A; Rosinol L; Mikala G; Krzystanski M; Lisch W; Vesole D; Szentmáry N; Jurczyszyn A
    Leuk Lymphoma; 2022 Apr; 63(4):984-990. PubMed ID: 34823428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.
    Zhan F; Barlogie B; Arzoumanian V; Huang Y; Williams DR; Hollmig K; Pineda-Roman M; Tricot G; van Rhee F; Zangari M; Dhodapkar M; Shaughnessy JD
    Blood; 2007 Feb; 109(4):1692-700. PubMed ID: 17023574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies.
    Korde N; Kristinsson SY; Landgren O
    Blood; 2011 May; 117(21):5573-81. PubMed ID: 21441462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MGUS, multiple myeloma, and paratarg-7.
    Lynch HT; Thomé S
    Lancet Oncol; 2009 Oct; 10(10):931-2. PubMed ID: 19796746
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma.
    Zingone A; Kuehl WM
    Semin Hematol; 2011 Jan; 48(1):4-12. PubMed ID: 21232653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does my patient with a serum monoclonal spike have multiple myeloma?
    Bianchi G; Ghobrial IM
    Hematol Oncol Clin North Am; 2012 Apr; 26(2):383-93, ix. PubMed ID: 22463833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of short-term, progressive exercise training on disease activity in smouldering multiple myeloma and monoclonal gammopathy of undetermined significance: a single-arm pilot study.
    Emery A; Moore S; Crowe J; Murray J; Peacock O; Thompson D; Betts F; Rapps S; Ross L; Rothschild-Rodriguez D; Arana Echarri A; Davies R; Lewis R; Augustine DX; Whiteway A; Afzal Z; Heaney J; Drayson MT; Turner JE; Campbell JP
    BMC Cancer; 2024 Feb; 24(1):174. PubMed ID: 38317104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.